LETTER
concentrated in vacuo. The residue was purified by silica-gel
Synthesis Based on Affinity Separation (SAS)
595
was added piperidine (20 l, 0.20 mmol). The mixture was
stirred at room temperature for 2 h, diluted with CH2Cl2 (8
ml), and then applied to the affinity separation. The desired 5-
ethyl-5-[4-(4-piperidino-3-nitrobenzoyl)oxymethyl-
benzyl]barbituric acid (25) was eluted at both CH2Cl2 and
CH2Cl2-MeOH (1:1) fractions. The CH2Cl2 fraction
column chromatography (hexane/EtOAc = 20:1 to 10:1) to
afford 8 (3.90 g, 97.7%). ESI-MS (positive) m/z 349.35
[(M+H)+, 18%]; 366.35 [(M+H2O)+, 40%]; 371.30 [(M+Na)+,
100%). 1H NMR (500 MHz, CDCl3), = 7.22 (2H, d, J = 7.7
Hz, Ar-H), 7.07 (2H, d, J = 8.0 Hz, Ar-H), 5.94 (1H, m,
CH2=CH-CH2-), 5.29 (1H, m, CH2=CH-CH2-), 5.19 (1H, m,
CH2=CH-CH2-), 4.47 (2H, s, -OCH2PhCH2-), 4.18 (4H, m, 2
-OCH2CH3), 4.01 (2H, m, CH2=CH-CH2-), 3.23 (2H, s, -
OCH2PhCH2-), 1.82 (2H, q, J = 7.6 Hz, -CH2CH3), 1.24 (6H,
t, J = 7.1 Hz, 2 -OCH2CH3), 0.92 (3H, t, J = 7.6 Hz, -
CH2CH3).
5-Ethyl-5-(4-allyloxymethylbenzyl)barbituric Acid (9). To a
solution of urea (7.00 g, 117 mmol) in DMSO (25 ml) was
added NaH (60% oil suspension, 2.0 g, 50 mmol) under N2.
After the mixture was stirred at room temperature for 30 min,
8 (4.10 g, 11.8 mmol) was added. The mixture was stirred at
room temperature for 14 h and then poured into 20 g of ice.
The mixture was acidified with 2M HCl and then extracted
with EtOAc. The organic layer was washed with water, dried
over Na2SO4, and concentrated in vacuo. The residue was
purified by silica-gel column chromatography (hexane/
EtOAc = 3:1 to 2:1) to give 9 (3.00 g, 80.6%). ESI-MS
(positive) m/z 339.15 [(M+Na)+]. 1H NMR (600 MHz,
CDCl3), = 7.86 (2H, s, NH), 7.22 (2H, d, J = 7.7 Hz, Ar-H),
7.08 (2H, d, J = 8 Hz, Ar-H), 5.93 (1H, m, CH2=CH-CH2-),
5.29 (1H, m, CH2=CH-CH2-), 5.20 (1H, m, CH2=CH-CH2-),
4.46 (2H, s, -OCH2PhCH2-), 4.00 (2H, m, CH2=CH-CH2-),
3.27(2H, s, -OCH2PhCH2-), 2.20 (2H, q, J = 7.6 Hz, -
CH2CH3), 0.92 (3H, t, J = 7.6 Hz, -CH2CH3).
containing 25 was concentrated and then applied to the
affinity separation again. The CH2Cl2-MeOH (1:1) fractions
were combined and concentrated. Compound 25 thus obtained
was dissolved in 0.2 M MeONa in MeOH (2.0 ml) and the
mixture was stirred at room temperature for 30 min. After
addition of AcOH (3 drops), the mixture was concentrated in
vacuo. The residue was dissolved in CHCl3 and then applied
to the affinity separation. The desired 26 was eluted with
CHCl3, whereas HOBA (10) was eluted with CH2Cl2/MeOH
(1:1). Evaporation of the solvent afforded 26 (24.0 mg,
90.9%). ESI-MS (positive) m/z 265.2 [(M+H)+]. 1H NMR
(600 MHz, CDCl3), = 8.42 (1H, s, Ar-H), 8.02 (1H, d,
J = 8.8 Hz, Ar-H), 7.05 (1H, d, J = 8.8 Hz, Ar-H), 3.90 (3H, s,
CH3), 3.15 (4H, t, NCH2), 1.72 (4H, m, CH2), 1.51 (2H, m,
CH2).
(11) Liu, W.-C.; Oikawa, M.; Fukase, K.; Suda, Y.; Kusumoto, S.
Bull. Chem. Soc., Jpn. 1999, 72, 1377.
(12) The experimental procedure for the preparation of
trisaccharide 34. The mixture of the glycosyl acceptor 30
(69.2 mg, 0.09 mmol), the glycosyl donor 31 (85 mg, 0.135
mmol), and MS 4A in CH2Cl2 (4 ml) was stirred at room
temperature for 1 h under N2 atmosphere and then cooled to
20 °C. TMSOTf (4.0 l, 22 mol) was added and the mixture
was stirred at the same temperature for 10 min. The mixture
was directly applied to the affinity separation to give
disaccharide 32. Disaccharide 32 was dissolved in CH2Cl2 (4
ml) containing 5% TFA and 1% water. The mixture was
stirred at 0 °C for 30 min, diluted with EtOAc (15 ml), washed
with saturated NaHCO3 solution and brine, dried over Na2SO4
and concentrated. The residue was applied to the affinity
separation to afford disaccharide acceptor 33. The mixture of
33 (59.2 mg, 0.0517 mmol), 31 (161 mg, 0.256 mmol), and
MS 4A in CH2Cl2 (5 ml) was stirred at room temperature for
1 h under N2, and then cooled to 20 C. TMSOTf (4.0 l, 22
mol) was added and the mixture was stirred at the same
temperature for 10 min. The mixture was directly applied to
the affinity separation to give 80.1 mg of the crude product,
which was then purified by silica-gel column chromatography
to afford the pure trisaccharide 34 (47.0 mg, 56.0%). ESI-MS
m/z 1630.0 [(M+Na)+]. 1H NMR (500 MHz, CDCl3), = 8.45
(2H, NH: barbituric acid), 7.45 (2H, m, Ph-H), 7.34 (3H, m,
Ph-H), 7.20 (2H, d, J = 7.6 Hz, Ph-H), 7.09 (2H, d, J = 8.1 Hz,
Ph-H), 6.28 (1H, br s, 2-NH: GlcNC), 5.92 (1H, m, CH2=CH-
CH2-), 5.51 (1H, s, PhCH=), 5.43 (1H, d, J = 9.9 Hz, 2-NH:
GlcNA), 5.37 (1H, br s, 2-NH: GlcNB), 5.33 (1H, m, CH2=CH-
CH2-), 5.24 (1H, m, CH2=CH-CH2-), 5.18 (1H, t, J = 9.7 Hz,
H-3: GlcNA), 5.13 (1H, t, J = 9.9 Hz, H-3: GlcNC), 5.05 (1H,
H-3: GlcNB), 5.02 (1H, d, J = 14 Hz, -OCH2PhCH2-), 4.97
(1H, d, J = 14 Hz, -OCH2PhCH2-). 4.90 (d, J = 3.7 Hz, 1H, H-
1: GlcNA), 4.79-4.65 (6H, CCl3CH2- 3), 4.65 (1H, d, J = 8.3
Hz, H-1: GlcNC), 4.63 (1H, d, J = 8.6 Hz, H-1: GlcNB), 4.37
(1H, dd, J = 5.6 Hz, 10.6 Hz, H-6: GlcNC), 4.22 (1H, m,
CH2=CH-CH2-), 4.21 (1H, H-6: GlcNB), 4.17 (1H, H-6:
GlcNA), 4.02 (1H, m, CH2=CH-CH2-), 3.96 (1H, H-5: GlcNA),
3.95 (1H, H-2: GlcNA), 3.84 (1H, H-6’: GlcNA), 3.82 (1H, H-
6’: GlcNC), 3.80 (1H, H-2: GlcNC), 3.79 (1H, H-6’: GlcNB),
3.71 (1H, H-4: GlcNC), 3.70 (1H, H-4: GlcNA), 3.62 (1H, H-
2: GlcNB), 3,53 (1H, H-5: GlcNB), 3.52 (1H, H-5: GlcNc), 3.51
(1H, H-4: GlcNB), 3.26 (2H, m, -OCH2PhCH2-), 2.35-2.22
(4H, m, -COCH2CH2CH2CO-), 2.18 (2H, q, J = 6.2 Hz,
CH3CH2-), 2.10 (3H, s, CH3CO-), 1.90 (2H, m, -
5-Ethyl-5-(4-hydroxymethylbenzyl)barbituric Acid (HOBA)
(10). To a degassed solution of 9 (2. 89 g, 9,13 mmol) in
anhydrous THF (100 ml) was added
[Ir(COD)(PMePPh2)]+PF6- (350 mg, 0.045 equiv) and the
solution was stirred under H2 at room temperature for 5 min
(the color of the solution changed from red to yellow) and then
for 100 min under N2. Water (45 ml) and iodine (4.4 g) was
added to the mixture successively. After the mixture was
stirred for 30 min, aqueous 10% Na2S2O3 solution (10 ml) was
added to quench the reaction. The mixture was extracted with
EtOAc and the organic layer was washed with brine, dried
over Na2SO4, and concentrated in vacuo. The residue was
purified by silica-gel column chromatography (CHCl3/
MeOH = 20:1) to give 10 (2.20 g, 87.3%). ESI-MS (positive)
m/z 575.3 [(2M+Na)+]; 315.1 [(M+K)+]; 299.2 [(M+Na)+]. 1H
NMR (600MHz, DMSO), = 7.18 (2H, d, J = 8 Hz, Ar-H),
6.94 (2H, d, J = 8 Hz, Ar-H), 5.15 (t, 1H, OH), 4.24 (2H, m,
-OCH2PhCH2-), 3.07 (2H, s, -OCH2PhCH2-), 1.97 (2H, q,
J = 7.6 Hz, -CH2CH3), 0.76 (3H, t, J = 7.6 Hz, -CH2CH3).
(8) General procedure for affinity separation. After completion of
the reaction, the reaction mixture was directly applied to the
resin 1 column (7.0 g: 1.5 cm 7 cm, CH2Cl2) unless
otherwise noted. After untagged compounds were washed off
with CH2Cl2 (70 ml), the tagged compound was eluted with
MeOH-CH2Cl2 (1:1) (30 ml). Evaporation of the solvents
afforded the desired product having the tag.
(9) Dankwardt, S. M.; Newman, S. R.; Krstenansky, J. L.
Tetrahedron Lett. 1995, 36, 4923.
(10) The experimental procedure for the preparation of methyl 4-
piperidino-3-nitrobenzoate (26). To a solution of HOBA (10)
(27.6 mg, 0.100 mmol), 4-fluruo-3-nitrobenzoic acid (22.0
mg, 0.119 mmol), and DMAP (1mg, 8 mol) in anhydrous
CH2Cl2 (3 ml) was added DIC (30 l, 0.19 mmol). The
mixture was stirred at room temperature for 2 h and then
applied to the affinity separation to give 5-ethyl-5-[4-(4-
fluruo-3-nitrobenzoyl)oxymethylbenzyl]barbituric acid (24).
To a solution of 24 in N-methylpyrrolidone (NMP) (0.8 ml)
Synlett 2001, No. 5, 590–596 ISSN 0936-5214 © Thieme Stuttgart · New York